Alldos

News Alldos

• Angiotech Pharmaceuticals and Athersys announce results from phase I study of Multistem in heart attack patients

  Angiotech Pharmaceuticals, Inc. and partner Athersys, Inc. announced updated results from its phase I clinical trial of MultiStem(R), its allogeneic cell therapy product, administered to individuals following acute myocardial infarction (AMI), more commonly referred to as a heart attack. The update more

• Genmab Announces Interim Results of Ofatumumab Phase II Study in Multiple Sclerosis

  Genmab A/S announced positive interim results from an ofatumumab Phase II safety and pharmacokinetics study in patients with relapsing-remitting multiple sclerosis (RRMS). A total of 38 patients were included in the trial, of which 12 patients received placebo and 26 patients received ofatumumab in more

• Intercell reports Phase II Study Results of its Vaccine Enhancement Patch for Pandemic Influenza

  Intercell AG announced the results of a Phase II clinical trial of its investigational Vaccine Enhancement Patch (VEP) system for avian H5N1 influenza. In this development program, Intercell is working under a contract with the U.S. Department of Health and Human Services (HHS) to develop a dose-spa more

Publications Alldos

• The Genome Portal of the Department of Energy Joint Genome Institute

  The Department of Energy (DOE) Joint Genome Institute (JGI) is a national user facility with massive-scale DNA sequencing and analysis capabilities dedicated to advancing genomics for bioenergy and environmental applications. Beyond generating tens of trillions of DNA bases annually, the Institute more

Websites Alldos